Greenland Mines Ltd. Common Stock (NASDAQ:GRML) Releases Earnings Results

Greenland Mines Ltd. Common Stock (NASDAQ:GRML) posted its quarterly earnings results on Monday. The company reported ($0.03) EPS for the quarter, Zacks reports.

Greenland Mines Ltd. Common Stock Stock Down 2.0%

Shares of NASDAQ GRML traded down $0.00 during midday trading on Monday, reaching $0.20. 4,741,389 shares of the company were exchanged, compared to its average volume of 4,195,392. The stock’s 50-day moving average price is $0.23 and its 200-day moving average price is $0.36. The stock has a market cap of $27.52 million, a P/E ratio of -0.62 and a beta of 7.13. Greenland Mines Ltd. Common Stock has a one year low of $0.16 and a one year high of $0.95.

Analyst Ratings Changes

Several research firms have commented on GRML. Weiss Ratings lowered shares of Greenland Mines Ltd. Common Stock from a “sell (d-)” rating to a “sell (e+)” rating in a report on Tuesday, August 11th. Wall Street Zen raised shares of Greenland Mines Ltd. Common Stock to a “sell” rating in a report on Saturday, May 2nd. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has an average rating of “Sell”.

Insiders Place Their Bets

In other news, Director Jason David Sawyer purchased 240,000 shares of the company’s stock in a transaction dated Wednesday, July 22nd. The stock was bought at an average cost of $0.23 per share, for a total transaction of $55,200.00. Following the purchase, the director owned 240,000 shares of the company’s stock, valued at approximately $55,200. The trade was a ∞ increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Riad Hussein El-Dada sold 175,000 shares of the firm’s stock in a transaction on Thursday, June 25th. The shares were sold at an average price of $0.23, for a total value of $40,250.00. Following the sale, the director directly owned 175,000 shares in the company, valued at approximately $40,250. This trade represents a 50.00% decrease in their position. The SEC filing for this sale provides additional information. 11.30% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Greenland Mines Ltd. Common Stock

Large investors have recently bought and sold shares of the company. XTX Topco Ltd boosted its stake in shares of Greenland Mines Ltd. Common Stock by 101.2% during the fourth quarter. XTX Topco Ltd now owns 160,569 shares of the company’s stock valued at $46,000 after purchasing an additional 80,768 shares in the last quarter. Jane Street Group LLC bought a new stake in shares of Greenland Mines Ltd. Common Stock during the fourth quarter worth about $64,000. Renaissance Technologies LLC bought a new stake in shares of Greenland Mines Ltd. Common Stock during the fourth quarter worth about $126,000. Finally, Geode Capital Management LLC increased its stake in shares of Greenland Mines Ltd. Common Stock by 51.8% in the fourth quarter. Geode Capital Management LLC now owns 491,832 shares of the company’s stock valued at $142,000 after buying an additional 167,905 shares during the period. 20.07% of the stock is currently owned by institutional investors.

About Greenland Mines Ltd. Common Stock

Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases – cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.